Clinical trial · Observational
Sellar Masses: Clinical and Imaging Features With Correlation to Histopathology and Surgical Approach
Sellar, Supra-sellar and Para-sellar Region Masses: Clinical Spectrum and Imaging Features With Correlation to Histopathology and Surgical Approach: A Prospective Descriptive Study.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this observational study is to learn about the clinical spectrum of sellar masses, aiming to understand the correlation between the imaging features and the future surgical approach and histopathology results. The main question it aims to answer is: Does being both LMIC and conflict country change the global data!? Participants were included during a period of 3 years in a governmental hospital TMGH.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pituitray Tumor | — | UNRESOLVED | — |
| Sellar Mass | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Craniectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients with confirmed sellar masses
- description
- Patients withe age of 11 to 65, who was diagnosed with sellar mass using MRI, and get treated surgically
- interventionNames
- Procedure: Craniectomy
Primary outcomes (1)
- measure
- Correlation between pre-operative radiological features and definitive histopathological diagnosis.
- timeFrame
- 3 years
- description
- To evaluate the diagnostic accuracy of pre-operative magnetic resonance imaging (MRI) by determining the percentage of cases where pre-operative radiological features match the definitive post-operative histopathological classification (e.g., pituitary adenoma, craniopharyngioma, meningioma).
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 11 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Radiologically confirmed sellar, suprasellar, or parasellar mass. * Surgical candidacy * Histopathological confirmation * Age ≥ 11 year Exclusion Criteria: * Incomplete diagnostics * Recurrent disease * Primary metastatic disease.
References
Publications (0)
Data not yet available